B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi –Specific Antibody-Secreting Cells Following Successful Etiological Treatment
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac495 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von G Cesar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben," Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Nitroimidazoles, Trypanocidal Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
A drawback in the treatment of chronic Chagas disease (American trypanosomiasis) is the long time required to achieve complete loss of serological reactivity, the standard for determining treatment efficacy.
Methods
Antibody-secreting cells and memory B cells specific for Trypanosoma cruzi and their degree of differentiation were evaluated in adult and pediatric study participants with chronic Chagas disease before and after etiological treatment.
Results
T. cruzi–specific antibody-secreting cells disappeared from the circulation in benznidazole or nifurtimox-treated participants with declining parasite-specific antibody levels after treatment, whereas B cells in most participants with unaltered antibody levels were low before treatment and did not change after treatment. The timing of the decay in parasite-specific antibody-secreting B cells was similar to that in parasite-specific antibodies, as measured by a Luminex-based assay, but preceded the decay in antibody levels detected by conventional serology. The phenotype of total B cells returned to a noninfection profile after successful treatment.
Conclusions
T. cruzi–specific antibodies in the circulation of chronically T. cruzi–infected study participants likely derive from both antigen-driven plasmablasts, which disappear after successful treatment, and long-lived plasma cells, which persist and account for the low frequency and long course to complete seronegative conversion in successfully treated participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Department, Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben," Buenos Aires, Argentina.
- Chagas Disease Unit, Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina.
- Center for Tropical and Emerging Global Diseases and Department of Cellular Biology, University of Georgia, Athens, Georgia, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Fund for Science and Technology of Argentina
- Ministerio de Salud de la Nación, Argentina
- Ministerio de Salud de la Provincia de Buenos Aires
Zitieren
APA
Cesar, G., Natale, M. A., Albareda, M. C., Alvarez, M. G., Lococo, B., De Rissio, A. M., Fernandez, M., Castro Eiro, M. D., Bertocchi, G., White, B. E., Zabaleta, F., Viotti, R., Tarleton, R. L., & Laucella, S. A. (2023). B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi –Specific Antibody-Secreting Cells Following Successful Etiological Treatment. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac495
Vancouver
Cesar G, Natale MA, Albareda MC, Alvarez MG, Lococo B, De Rissio AM, et al. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi –Specific Antibody-Secreting Cells Following Successful Etiological Treatment. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac495
BibTeX
@article{Cesar2023,
author = {Cesar, G and Natale, M A and Albareda, M C and Alvarez, M G and Lococo, B and De Rissio, A M and Fernandez, M and Castro Eiro, M D and Bertocchi, G and White, B E and Zabaleta, F and Viotti, R and Tarleton, R L and Laucella, S A},
title = {B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi –Specific Antibody-Secreting Cells Following Successful Etiological Treatment},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac495}
}
EUVIMED